Cover Image

Developing a comprehensive Cardio-Oncology Program at a Cancer Institute: the Moffitt Cancer Center experience

Michael G. Fradley, Allen C. Brown, Bernadette Shields, Federico Viganego, Rongras Damrongwatanasuk, Aarti A. Patel, Gregory Hartlage, Natalee Roper, Julie Jaunese, Larry Roy, Roohi Ismail-Khan
  • Michael G. Fradley
    Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute; Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States | mfradley@health.usf.edu
  • Allen C. Brown
    Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States
  • Bernadette Shields
    Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States
  • Federico Viganego
    Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute; Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States
  • Rongras Damrongwatanasuk
    Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute; Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States
  • Aarti A. Patel
    Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States
  • Gregory Hartlage
    Division of Cardiovascular Medicine, University of South Florida, Tampa, FL, United States
  • Natalee Roper
    Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States
  • Julie Jaunese
    Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States
  • Larry Roy
    Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States
  • Roohi Ismail-Khan
    Cardio-Oncology Program, H. Lee Moffitt Cancer Center and Research Institute; Women’s Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States

Abstract

Cardio-oncology is a multidisciplinary field focusing on the management and prevention of cardiovascular complications in cancer patients and survivors. While the initial focus of this specialty was on heart failure associated with anthracycline use, novel anticancer agents are increasingly utilized and are associated with many other cardiotoxicities including hypertension, arrhythmias and vascular disease. Since its inception, the field has developed at a rapid pace with the establishment of programs at many major academic institutions and community practices. Given the complexities of this patient population, it is important for providers to possess knowledge of not only cardiovascular disease but also cancer subtypes and their specific therapeutics. Developing a cardio- oncology program at a stand-alone cancer center can present unique opportunities and challenges when compared to those affiliated with other institutions including resource allocation, cardiovascular testing availability and provider education. In this review, we present our experiences establishing the cardio-oncology program at Moffitt Cancer Center and provide guidance to those individuals interested in developing a program at a similar independent cancer institution.

Keywords

Cardio-Oncology; cardiotoxicity; chemotherapy.

Full Text

PDF
Submitted: 2017-04-17 20:53:52
Published: 2017-07-18 12:03:13
Search for citations in Google Scholar
Related articles: Google Scholar
Abstract views:
306

Views:
PDF
177

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


Copyright (c) 2017 Michael G. Fradley, Allen C. Brown, Bernadette Shields, Federico Viganego, Rongras Damrongwatanasuk, Aarti A. Patel, Gregory Hartlage, Natalee Roper, Julie Jaunese, Larry Roy, Roohi Ismail-Khan

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 
© PAGEPress 2008-2017     -     PAGEPress is a registered trademark property of PAGEPress srl, Italy.     -     VAT: IT02125780185